BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32241341)

  • 1. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
    Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
    Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
    Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
    Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
    Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
    Wang L; Zhong Q; Tang Q; Wang H
    Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
    Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
    Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study.
    Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
    Fertil Steril; 2021 Jan; 115(1):157-163. PubMed ID: 32977941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
    Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
    Huang Y; Zhang W; Wang Y
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
    Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
    Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
    Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
    Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and fertility outcomes of patients with borderline ovarian tumors after fertility-sparing surgery].
    Zhang Y; Wang QN; Huang Z; Chu R; Dong TT; Zhang YZ; Yang XS; Jiang J; Cui BX; Song K; Kong B
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1999-2004. PubMed ID: 35817724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.